Jubilee Metals Group PLC (JUBPF)

Market Cap	135.22M
Revenue (ttm)	253.20M
Net Income (ttm)	2.65M
Shares Out	n/a
EPS (ttm)	0.00
PE Ratio	50.93
Forward PE	3.45
Dividend	n/a
Ex-Dividend Date	n/a

Volume	58,000
Average Volume	10,550
Open	0.0482
Previous Close	0.0500
Day's Range	0.0480 - 0.0500
52-Week Range	0.0340 - 0.0900
Beta	1.34
RSI	34.62
Earnings Date	Oct 3, 2025

About Inozyme Pharma

Jubilee Metals Group plc operates as a diversified metals processing and recovery company. It operates through Copper and Cobalt, PGM and Chrome, and Other segments. The company explores for platinum group metals, such as platinum, palladium, rhodium, iridium, osmium, and gold; and chrome, lead, zinc, vanadium, copper, nickel, and cobalt deposits. It holds interests in the Sable refinery, Roan concentrator, Kitwe, and Munkoyo properties located in Zambia; and the Inyoni, Thutse, and Windsor projects located in South Africa. The company also hol...

• Industry: Other Industrial Metals & Mining
• Sector: Materials
• Founded: 2001
• Employees: 885
• Stock Exchange: OTCMKTS
• Ticker Symbol: JUBPF

Financial Performance

In 2024, Jubilee Metals Group's revenue was $205.40 million, an increase of 20.19% compared to the previous year's $170.90 million. Earnings were $5.95 million, a decrease of -61.70%.